Leptin is differentially expressed and epigenetically regulated across monochorionic twin placenta with discordant fetal growth

Molecular Human Reproduction

Volumn 19, Issue 11, 2013, Pages 764-772

  Schrey, S ^a   Kingdom, J ^a   Baczyk, D ^b   Fitzgerald, B ^c   Keating, S ^c   Ryan, G ^a   Drewlo, S ^b,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Discordant growth; Leptin; Multiple pregnancy; Placenta

Indexed keywords

ENDOGLIN; FMS LIKE TYROSINE KINASE 1; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANEMIA; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FEMALE; FETUS GROWTH; GENE CONTROL; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MALE; METABOLIC SYNDROME X; MONOCHORIONIC TWIN PREGNANCY; NEWBORN; PATIENT SELECTION; PHENOTYPE; PLACENTA; POLYCYTHEMIA; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE SIZE; TWIN ANEMIA POLYCYTHEMIA SEQUENCE; TWIN DISCORDANCE; TWIN PREGNANCY; TWIN TWIN TRANSFUSION SYNDROME; UPREGULATION;

ANGIOGENESIS; DISCORDANT GROWTH; LEPTIN; MULTIPLE PREGNANCY; PLACENTA;

DISEASES IN TWINS; EPIGENESIS, GENETIC; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; LEPTIN; MALE; PLACENTA; PREGNANCY; PREGNANCY, TWIN; TWINS, MONOZYGOTIC;

EID: 84887006012     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gat048     Document Type: Article

References (37)

1. Baczyk D, Satkunaratnam A, Nait-Oumesmar B, Huppertz B, Cross JC, Kingdom JC. Complex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placenta. Placenta 2004; 25:553-559.
2. Baschat A, Chmait RH, Deprest J, Gratacos E, Hecher K, Kontopoulos E, Quintero R, Skupski DW, Valsky DV, Ville Y. Twin-to-twin transfusion syndrome (TTTS). J Perinat Med 2011;39:107-112.
3. Bejar R, Vigliocco G, Gramajo H, Solana C, Benirschke K, Berry C, Coen R, Resnik R. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol 1990;162:1230-1236.
4. Cameo P, Bischof P, Calvo JC. Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culture. Biol Reprod 2003;68:472-477.
5. Cerdeira AS, Karumanchi SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med 2012;2:a006585ent.
6. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. molecular regulation. Placenta 2004;25:103-113.
7. Clapp JF III, KiessW. Cord blood leptin reflects fetal fat mass. J Soc Gynecol Investig 1998;5:300-303.
8. De Larco JE, Wuertz BR, Yee D, Rickert BL, Furcht LT. Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc Natl Acad Sci USA 2003;100:13988-13993.
9. De Paepe ME, Shapiro S, Greco D, Luks VL, Abellar RG, Luks CH, Luks FI. Placental markers of twin-to-twin transfusion syndrome in diamniotic-monochorionic twins: a morphometric analysis of deep artery-to-vein anastomoses. Placenta 2010;31:269-276.
10. Duncan KR, Denbow ML, Fisk NM. The aetiology and management of twin-twin transfusion syndrome. Prenat Diagn 1997;17:1227-1236.
11. Fick AL, Feldstein VA, Norton ME,Wassel Fyr C, Caughey AB, Machin GA. Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins. Am J Obstet Gynecol 2006;195:178-183.
12. Galea P, Barigye O, Wee L, Jain V, Sullivan M, Fisk NM. The placenta contributes to activation of the renin angiotensin system in twin-twin transfusion syndrome. Placenta 2008;29:734-742.
13. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004;25:114-126.
14. KelavkarUP,HaryaNS,Hutzley J, Bacich DJ,Monzon FA,Chandran U,Dhir R, O'Keefe DS. DNA Methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Prostaglandins Other Lipid Mediat 2007;82:185-197.
15. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, Blondel B, Breart G. A new and improved population-based canadian reference for birth weight for gestational age. Pediatrics 2001;108:E35.
16. Kusanovic JP, Romero R, Espinoza J, Nien JK, KimCJ,Mittal P, Edwin S, ErezO, Gotsch F, Mazaki-Tovi S et al. Twin-to-twin transfusion syndrome: an antiangiogenic state? Am J Obstet Gynecol 2008;198:382 e381-e388.
17. Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod 2000;6:763-769.
18. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH et al. Circulating angiogenic factors and the risk of preeclampsia. NEJM 2004;350:672-683.
19. Linnemann K, Malek A, Sager R, Blum WF, Schneider H, Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab 2000;85:4298-4301.
20. Lopriore E,Ortibus E,Acosta-Rojas R, LeCessie S,Middeldorp JM,Oepkes D, Gratacos E, Vandenbussche FP, Deprest J,Walther FJ et al. Risk factors for neurodevelopment impairment in twin-twin transfusion syndrome treated with fetoscopic laser surgery. Obstet Gynecol 2009;113:361-366.
21. Lopriore E, Slaghekke F, Middeldorp JM, Klumper FJ, van Lith JM,Walther FJ, Oepkes D. Accurate and simple evaluation of vascular anastomoses in monochorionic placenta using colored dye. J Vis Exp 2011;5:e3208.
22. Marchi M, Lisi S, Curcio M, Barbuti S, Piaggi P, Ceccarini G, Nannipieri M, Anselmino M, Di Salvo C, Vitti P et al. Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter Epigenetics 2011;6:1198-1206.
23. MayhewTM. Fetoplacental angiogenesis during gestation isbiphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta 2002;23:742-750.
24. Mayhew TM, Charnock-JonesDS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004;25:127-139.
25. Maymo JL, Perez AP, Gambino Y, Calvo JC, Sanchez-Margalet V, Varone CL. Review: Leptin gene expression in the placenta-regulation of a key hormone in trophoblast proliferation and survival. Placenta 2011;32:S146-S153.
26. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, Post M, Bocking A, Todros T, Caniggia I. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008;93:285-292.
27. Parrott MS, von Versen-Hoeynck F, Ness RB, Markovic N, Roberts JM. System A amino acid transporter activity in term placenta is substrate specific and inversely related to amino acid concentration. Reprod Sci 2007;14:687-693.
28. Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta 2008;29:86-91.
29. Redline RW, Boyd T, Campbell V, Hyde S, Kaplan C, Khong TY, PrashnerHR, Waters BL.Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:237-249.
30. Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, Takemura M, Nuamah MA, Ogawa Y, Masuzaki H et al. Role of leptin in pregnancy-a review. Placenta 2002;23:80-86.
31. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90:4895-4903.
32. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ et al. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-1686.
33. Sooranna SR,Ward S,BajoriaR. Discordant fetal leptinlevels inmonochorionic twins with chronic midtrimester twin-twin transfusion syndrome. Placenta 2001a;22:392-398.
34. Sooranna SR,Ward S, Bajoria R. Fetal leptin influences birth weight in twins with discordant growth. Pediatr Res 2001b;49:667-672.
35. Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta 2013;34:205-211.
36. Tsatsaris V,Goffin F, Munaut C, Brichant JF, PignonMR,Noel A, Schaaps JP, Cabrol D, Frankenne F, Foidart JM. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003;88: 5555-5563.
37. Tzschoppe A, Struwe E, Rascher W, Dorr HG, Schild RL, Goecke TW, Beckmann MW, Hofner B, Kratzsch J, Dotsch J. Intrauterine growth restriction (IUGR) is associated with increased leptin synthesis and binding capability in neonates. Clin Endocrinol (Oxf) 2011;74:459-466.